Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: the PROTHROMCOVID Randomized Controlled Trial
Journal of Clinical Medicine(2022)
Key words
COVID-19,pulmonary embolism,thrombosis,respiratory insufficiency,low-molecular-weight heparin
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined